MedTrace Logo

Impact of Sleep Apnea on Diabetic Foot Wound.

NCT01573897 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2018-06-28

No results posted yet for this study

Summary

Sleep apnea syndrome (SAS) is a common comorbidity of type 1 and type 2 diabetes. A low transcutaneous oxygen tension (PtcO2) measured on the foot is pejorative prognostic factor for the healing of a diabetic foot wound. SAS causes intermittent nocturnal hypoxia and sympathetic overactivity. The investigators hypothesized that SAS could be a factor reducing the PtcO2.Therefore, the main objective of this study is to assess the variation in PtcO2 between the end of the night and midday in patients with -or at risk of- diabetic foot wound according to the presence or not of sleep apnea syndrome.The secondary objective is to address the microvascularisation of diabetic patients having foot wounds according to their status regarding sleep apnea syndrome.

Conditions

Sponsors & Collaborators

  • AGIR à Dom

    lead OTHER

Principal Investigators

  • Anne-Laure Borel, Pr MD PhD · Diabetes and Endocrinology Unit, Grenoble University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-04
Primary Completion
2016-11-15
Completion
2016-11-15

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01573897 on ClinicalTrials.gov